Phreesia, Inc. (NYSE:PHR) SVP David Linetsky Sells 11,853 Shares

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 11,853 shares of the stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $24.85, for a total value of $294,547.05. Following the sale, the senior vice president now owns 188,354 shares in the company, valued at approximately $4,680,596.90. This represents a 5.92 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

David Linetsky also recently made the following trade(s):

• On Friday, October 18th, David Linetsky sold 1,100 shares of Phreesia stock. The shares were sold at an average price of $20.49, for a total value of $22,539.00.
• On Tuesday, October 15th, David Linetsky sold 2,011 shares of Phreesia stock. The shares were sold at an average price of $21.03, for a total value of $42,291.33.
• On Thursday, September 19th, David Linetsky sold 24 shares of Phreesia stock. The shares were sold at an average price of $24.04, for a total value of $576.96.
• On Tuesday, September 17th, David Linetsky sold 36 shares of Phreesia stock. The shares were sold at an average price of $24.77, for a total value of $891.72.

Phreesia Trading Up 1.6 %

Shares of Phreesia stock opened at $24.94 on Friday. The firm has a market cap of $1.45 billion, a price-to-earnings ratio of -16.97 and a beta of 0.98. The business has a 50-day moving average price of $20.45 and a 200-day moving average price of $21.82. The company has a quick ratio of 1.77, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.16.

Phreesia (NYSE:PHR) last issued its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million during the quarter, compared to analyst estimates of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.58) earnings per share. Equities research analysts anticipate that Phreesia, Inc. will post -1.22 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

PHR has been the topic of several research analyst reports. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a report on Tuesday. JMP Securities reissued a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a report on Tuesday. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $34.00 target price on shares of Phreesia in a report on Thursday, September 5th. Robert W. Baird decreased their target price on Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday. Finally, JPMorgan Chase & Co. raised their target price on Phreesia from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, September 9th. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $29.33.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in PHR. Diversified Trust Co grew its position in Phreesia by 102.0% in the second quarter. Diversified Trust Co now owns 21,574 shares of the company’s stock worth $457,000 after acquiring an additional 10,893 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Phreesia by 8.4% in the second quarter. Bank of New York Mellon Corp now owns 214,430 shares of the company’s stock worth $4,546,000 after purchasing an additional 16,614 shares during the last quarter. Peregrine Capital Management LLC lifted its stake in Phreesia by 11.3% in the second quarter. Peregrine Capital Management LLC now owns 354,607 shares of the company’s stock worth $7,518,000 after purchasing an additional 36,047 shares during the last quarter. nVerses Capital LLC lifted its stake in Phreesia by 76.5% in the second quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock worth $64,000 after purchasing an additional 1,300 shares during the last quarter. Finally, Rhumbline Advisers lifted its stake in Phreesia by 1.0% in the second quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after purchasing an additional 853 shares during the last quarter. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.